Browsing by Author Roughead, E. E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2014Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?Boyle, Frances; Bulsara, Max; Kemp, Anna; Malacova, Eva; Preen, David; Roughead, E. E.; Saunders, Christobel; Northern Clinical School: MedicineEarly discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?, SpringerPlus, vol.3, 1, 2014,pp 1-10
2015Reducing inappropriate polypharmacy: the process of deprescribingGnjidic, Danijela; Hilmer, Sarah; Jansen, Jesse; Le Couteur, David; Reeve, Emily; Del Mar, Chris; Martin, J; Page, Andrew; Potter, Kathleen; Rigby, D; Roughead, E. E.; Scott, I; Pharmacy; Northern Clinical School: Medicine; School of Public Health: Screening & Test Evaluation Program; Concord Clinical School: ANZAC Research Institute; Northern Clinical School: Kolling InstituteReducing inappropriate polypharmacy: the process of deprescribing, JAMA Internal Medicine, vol.175, 5, 2015,pp 827-834
2014Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choiceBoyle, Frances; Bulsara, Max; Holman, D'Arcy; Kemp, Anna; Malacova, Eva; Preen, David; Roughead, E. E.; Saunders, Christobel; Northern Clinical School: MedicineWomen commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice, PloS One, vol.9, 1, 2014,pp 1-8